HLA antigen expression in enteropathy associated T cell lymphoma.
OBJECTIVE
To investigate the occurrence of abnormal patterns of HLA-ABC and HLA-DR expression in enteropathy associated T cell lymphoma and to relate such abnormalities to the Epstein Barr virus (EBV) status of the tumours.


METHODS
Eleven enteropathy associated T cell lymphomas were immunostained with HC10 (HLA-ABC heavy chain) and TAL 1B5 (HLA-DR alpha chain) monoclonal antibodies and polyclonal anti-beta 2 microglobulin (beta 2m, the HLA-ABC light chain) antibodies. In situ hybridisation for EBV using EBER probes was performed on all cases.


RESULTS
Tumour cells of two of 11 patients were EBER positive. One of these showed partial, and the other, complete loss of beta 2m. HLA-DR expression was undetectable in both patients. Of the remaining nine EBER negative tumours, two were HLA-ABC heavy chain negative or showed only occasional positive cells and five of nine showed partial or complete loss of the HLA-ABC light chain, beta 2m. Seven of the nine cases were either negative for HLA-DR or showed weak expression in a proportion of tumour cells.


CONCLUSIONS
These data show that low or absent HLA-ABC and HLA-DR antigen expression occurs commonly in enteropathy associated T cell lymphoma. These abnormal patterns of HLA expression may be associated with escape from immune attack which, in a minority of patients, could be directed against EBV antigens.
Ashton-Key
M
M
Department of Histopathology, University College London Medical School, London.
Singh
N
N
Pan
L X
LX
Smith
M E
ME
D015234:HLA-A Antigens / Q000302:isolation & purification*; D006684:HLA-DR Antigens / Q000302:isolation & purification*; D004854:Herpesvirus 4, Human / Q000302:isolation & purification; D006801:Humans; D007150:Immunohistochemistry; D007414:Intestinal Neoplasms / Q000276:immunology* / Q000821:virology; D016399:Lymphoma, T-Cell / Q000276:immunology* / Q000821:virology
D015234:HLA-A Antigens; D006684:HLA-DR Antigens